Promoter Methylation of MMP9 and RUNX3: Diagnostic Potential and Clinical Associations in Rheumatoid Arthritis
Amir Mohamad Mohamadizad Moghadam, Yousef Mohammadi, Shahrouz Khoshbakht, Ruhollah Mirjani, Ali Zarei, Mohsen Ghasemzadeh Soroush, Seyyed Mohamad Hoseini, Meysam Mosallaei · 2025
Read Promoter Methylation of MMP9 and RUNX3: Diagnostic Potential and Clinical Associations in Rheumatoid Arthritis by Amir Mohamad Mohamadizad Moghadam, Yousef Mohammadi, Shahrouz Khoshbakht, Ruhollah Mirjani, Ali Zarei, Mohsen Ghasemzadeh Soroush, Seyyed Mohamad Hoseini, Meysam Mosallaei (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12885186.txt.
Description
Amir Mohamad Mohamadizad Moghadam and seven colleagues tested gene methylation in blood as a test sign for rheumatoid arthritis. Signs in use now for the joint disease, where the body attacks itself, have real limits. Methylation, a chemical dimmer switch on genes, might offer a better signal. The team measured methylation at the start of two genes, MMP9 and RUNX3, in blood cells. Seventy-two patients and seventy-two healthy controls were compared.
MMP9 methylation was much lower in patients, averaging about thirty-eight percent against sixty-two percent in controls. That low pattern held up in the stats. RUNX3 methylation showed no such gap. The team also linked methylation with swelling markers like C-reactive protein. The 2025 study backs one of the two genes as a possible blood test for rheumatoid arthritis.
Catalog record
| CREATOR | Amir Mohamad Mohamadizad Moghadam, Yousef Mohammadi, Shahrouz Khoshbakht, Ruhollah Mirjani, Ali Zarei, Mohsen Ghasemzadeh Soroush, Seyyed Mohamad Hoseini, Meysam Mosallaei |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |